17-alpha-hydroxyprogesterone has been researched along with Benign Cranial Nerve Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Comite, F; Cutler, GB; Hench, K; Laue, L; Loriaux, DL; Pescovitz, OH | 1 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Benign Cranial Nerve Neoplasms
Article | Year |
---|---|
Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
Topics: 17-alpha-Hydroxyprogesterone; Child; Child, Preschool; Chorionic Gonadotropin; Cortodoxone; Cranial Nerve Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Glioma; Gonadotropin-Releasing Hormone; Growth; Humans; Hydroxyprogesterones; Luteinizing Hormone; Male; Neurofibromatosis 1; Optic Nerve Diseases; Puberty, Precocious; Skin Neoplasms; Testosterone; Triptorelin Pamoate | 1985 |